Lv3
400 积分 2022-10-28 加入
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
3天前
已完结
Treatment of Scalp Psoriasis
3个月前
已完结
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
3个月前
已完结
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
9个月前
已完结
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
2年前
已完结
Patient-centric trials for therapeutic development in precision oncology
2年前
已完结
Early Use of Systemic Corticosteroids in Patients with Advanced NSCLC Treated with Nivolumab
2年前
已完结
Immune Checkpoint Inhibitor Outcomes for Patients With Non–Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications
2年前
已完结
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
2年前
已完结
皖公网安备34019202002308
